Battlefield Acupuncture for Acute/Subacute Back Pain in the Emergency Department
CompletedNot applicableNCT03996564
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The randomized controlled study aims was to investigate the pain control of Battle Field Acupuncture as Primary or Adjunctive Treatment in Back Pain (Acute Musculoskeletal pain) in the (acute pain setting) Emergency Department vs stand of care pain medications.
Study details
- Official title
- Battlefield Acupuncture for Acute/Subacute Back Pain in the Emergency Department
- Conditions
- Interventions
- Device: Battlefield Acupuncture
- Drug: Acetaminophen
- Drug: Diclofenac
- Drug: Diazepam
- Drug: Hydrocodone
- Drug: Ketorolac
- Sponsor
- San Antonio Military Medical Center
- Start date
- 2016-02-22
- Primary completion
- 2016-12-12
- Sex
- All
- Age range
- from 18 Years to 55 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Individuals to be enrolled the study will be: * Emergency Room patient * Able to provide informed consent (of sound mind) * acute defined as less than 3 months, or acute on chronic musculoskeletal pain * Individuals will be between 18-55 years of age and include Active Duty (AD) service members and beneficiaries * Pain at prescreening will be greater than or equal to 3 based on the Visual Analogue Scale (VAS). * Non-pathological acute back pain Exclusion Criteria: * The individuals eligible for the study will be in good health, as defined by the World Health Organization (WHO, 2006). "Health is a state of complete physical, mental, and social wellbeing and not merely the absence of disease or infirmity" (WHO, 2006). Specific exclusion criteria will include, * Participants presenting with open wound injuries * temperature \>38.0 Celsius * suspected fractures * pain associated with diseases (flank/kidney pain) * concern for other than back pain (pyelonephritis, kidney stones, pathologic signs and symptoms) * bowel/bladder incontinence or retention * foot drop * known current/history of cancer * known bleeding disorders * active infection at the needled insertion site * If member is found to be pregnant at any time during screening process they will be removed from consideration before any treatment options are offered.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03996564